meta_analysis
2022
Influence of Age and Dose on the Effect of Resveratrol for Glycemic Control in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Garcia-Martinez BI, Ruiz-Ramos M, Pedraza-Chaverri J, Santiago-Osorio E, Mendoza-Nunez VM
Published in Molecules
Key Findings
Glycemic benefits of resveratrol were concentrated in participants under 60 years and at doses of about 1000 mg/day, with little effect in older adults.
Conclusions
Effects depend strongly on age and dose.
Limitations
Subgroup findings from a modest number of trials.
Supplements Studied
Resveratrol
Compound
Glycemic benefits were concentrated in participants under 60 years and at doses around 1000 mg/day.
Outcomes Measured
Glycemic effects of resveratrol depended on age and dose.
Related Health Concerns
Study Details
Year:2022
00Quality Score:6/10
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.